| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
4,726 |
3,907 |
$682K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
726 |
690 |
$316K |
| 81025 |
|
1,855 |
1,781 |
$212K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,842 |
4,428 |
$211K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,759 |
1,507 |
$165K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
725 |
682 |
$150K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,929 |
547 |
$138K |
| 36415 |
Collection of venous blood by venipuncture |
41 |
36 |
$108K |
| 81001 |
|
2,310 |
2,113 |
$107K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
810 |
750 |
$105K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,218 |
3,578 |
$92K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,512 |
518 |
$87K |
| 81003 |
|
1,414 |
1,308 |
$80K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
896 |
691 |
$72K |
| J3490 |
Unclassified drugs |
806 |
250 |
$58K |
| J2704 |
Injection, propofol, 10 mg |
1,528 |
1,340 |
$53K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
346 |
290 |
$41K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
939 |
421 |
$41K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,070 |
1,596 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,228 |
967 |
$38K |
| 87081 |
|
1,222 |
1,181 |
$33K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
985 |
328 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,901 |
1,679 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,042 |
5,696 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
311 |
285 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,008 |
754 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,173 |
1,086 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
1,165 |
1,050 |
$14K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
174 |
148 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,064 |
1,796 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
82 |
76 |
$11K |
| 82962 |
|
368 |
216 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,902 |
1,624 |
$8K |
| A9150 |
Non-prescription drugs |
127 |
71 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,373 |
1,906 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
75 |
66 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,558 |
1,163 |
$3K |
| 87430 |
|
377 |
368 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
112 |
102 |
$2K |
| 87070 |
|
26 |
24 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
169 |
162 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
158 |
101 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,506 |
1,400 |
$2K |
| 84703 |
|
726 |
683 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
65 |
59 |
$1K |
| 84484 |
|
1,132 |
931 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19 |
17 |
$869.58 |
| 84702 |
|
65 |
53 |
$741.35 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,900 |
1,476 |
$675.47 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
14 |
$606.33 |
| 85610 |
|
626 |
560 |
$305.44 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
201 |
188 |
$266.43 |
| 97161 |
|
12 |
12 |
$262.72 |
| 86850 |
|
58 |
52 |
$216.80 |
| 83690 |
|
1,405 |
1,211 |
$215.17 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
116 |
86 |
$102.60 |
| 83735 |
|
1,115 |
959 |
$66.61 |
| 87077 |
|
60 |
54 |
$43.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,204 |
1,061 |
$40.08 |
| 83880 |
|
13 |
12 |
$33.89 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,681 |
1,457 |
$30.69 |
| 86900 |
|
509 |
463 |
$27.47 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,756 |
2,334 |
$24.11 |
| 86901 |
|
509 |
463 |
$19.80 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,989 |
1,678 |
$13.83 |
| 85730 |
|
442 |
400 |
$10.66 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
91 |
73 |
$9.68 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
64 |
50 |
$6.83 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,485 |
1,070 |
$2.14 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
26 |
26 |
$0.00 |
| 87186 |
|
256 |
230 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
24 |
24 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
35 |
26 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
16 |
15 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
346 |
253 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
990 |
919 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
21 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
88 |
63 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
12 |
12 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
50 |
50 |
$0.00 |
| 96376 |
|
74 |
55 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
24 |
24 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
112 |
99 |
$0.00 |
| 86592 |
|
12 |
12 |
$0.00 |
| 85027 |
|
13 |
12 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$0.00 |